baber/WOPTO huggingface dataset:
Patent NZ-544155-A (NZ)
Title: Carboxylic acid compound and medicine containing the same
Inventor: INOUE KEISUKE
IPC: A61P9/00
Filed: 2004-05-21
Abstract: Disclosed is a compound selected from the group consisting of 2,2-dichloro-12-(4-chlorophenyl)-10-hydroxydodecanoic acid and 2,2-dichloro-12-(4-chlorophenyl)-11-hydroxydodecanoic acid, a salt thereof, or an ester thereof. The compounds are useful in the treatment of diseases such as hyperlipemia, atherosclerosis, diabetes, complications of diabetes, inflammation and cardiopathy.
Patent NZ-551144-A (NZ)
Title: Cinnamide compound
Inventor: KIMURA TEIJI
IPC: C07D401/04
Filed: 2005-05-25
Abstract: Disclosed is a compound represented by the formula (I): (wherein Ar1 represents imidazolyl optionally substituted by one to three substituents; Ar2 represents a pyridinyl, pyrimidinyl, or phenyl group optionally substituted by one to three substituents; X1 represents (1) -Ca"C- or (2) an optionally substituted double bond, etc.; and R1 and R2 each represents optionally substituted C1-6 alkyl, C3-8 cycloalkyl, etc.) or a pharmacologically acceptable salt of the compound; and a use of the compound or salt as a medicine for the treatment/prophylaxis of a disease resulting from amyloid betas, wherein the disease is selected from Alzheimer's disease, senile dementia, Down syndrome or amyloidosis.
Patent NZ-556163-A (NZ)
Title: Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
Inventor: HAMMOCK BRUCE D
IPC: A61K31/415
Filed: 2006-01-10
Abstract: Disclosed is the use of an inhibitor of soluble epoxide hydrolase ("sEH") and an enzyme selective inhibitor of cyclo-oxygenase-2 (COX-2) in the preparation of a medicament for reducing pain and/or inflammation, wherein said medicament is formulated for co-administering said inhibitor of sEH and said selective inhibitor of COX-2, wherein said inhibitor of sEH has a primary pharmacophore selected from the group consisting of a urea, a carbamate, and an amide, and wherein said selective inhibitor of COX-2 is selected from the group consisting of celecoxib, valdecoxib, lumiracoxib, etoricoxib, and rofecoxib.
Patent NZ-561958-A (NZ)
Title: Impulse generator for car ignition system
Inventor: LIU LINMING
Filed: 2007-09-27
Abstract: A device parallel-connected between the positive and negative terminals of the battery of the ignition system of a car, is disclosed. The device comprises: (a) a transistor whose emitter is connected to the negative terminal of the battery; (b) an inductor having one terminal connected to the collector of the transistor and the other terminal connected to the positive terminal of the battery; and (c) an oscillator whose output is connected to the base of the transistor. The device produces high-frequency pulses running through a primary, low voltage, circuit of the ignition system. The high-frequency pulses induce similarly high-frequency pulses on a secondary, high voltage, circuit via an ignition coil of the ignition system and the induced high-frequency pulses run through spark plugs via the secondary circuit for preventing the build-up of electrically resistive materials between terminals of the spark plugs.
Patent NZ-567203-A (NZ)
Title: Microbicidal dendrimer composition delivery system for treatment and prevention of sexually transmitted infections
Inventor: GROGAN OWEN TIMOTHY
IPC: A61F6/10
Filed: 2006-02-01
Abstract: Disclosed is a microbicidal delivery system including: a microbicidal composition including a microbicidal compound including a dendrimer including one or more surface groups of formula (IV); a microbicidally active derivative thereof, or pharmaceutically acceptable salt or solvate thereof; and a carrier, excipient or diluent therefor; and a prophylactic device; the microbicidal composition being carried on a surface of the prophylactic device or impregnated into the prophylactic device or covalently bound to the surface of the prophylactic device and being compatible therewith.
Patent NZ-568075-A (NZ)
Title: Treatment of ocular neovascular disorders such as macular degeneration, angoid streaks, uveitis and macular edema
Inventor: BRIGANDI RICHARD ANTHONY
IPC: A61K31/506
Filed: 2006-11-29
Abstract: Disclosed is an indazole-pyrimidine amino derivative of formula (I), or a salt or solvate thereof, for the treatment of ocular neovascular disorders by administration directly to the eye.
Patent NZ-569621-A (NZ)
Title: Sheet pile in double-T form
Inventor: HERMES ALOYSE
IPC: E02D5/04
Filed: 2006-12-19
Abstract: Disclosed is a steel sheet pile in double-T form. The pile includes a web and two flanges. Each flange has an inner side facing the web, an outer side facing away from the web, and two longitudinal edges. A coupling means for a connection profile is provided along at least one longitudinal edge of at least one flange end. The coupling means is formed by a milled groove which extends in the outer side of the flange along the at least one longitudinal edge and has a substantially V-shaped cross section with an opening width (b) lying within the range (0.5 e) d" b d" (1.5 e) and with a depth (t) lying within the range 10 mm d" t d" (0.5 e), where (e) is the thickness of the flange in the direct vicinity of the groove.
Patent NZ-570537-A (NZ)
Title: Herbicidal composition comprising flazasulfuron, foramsulfuron, halosulfuronmethyl, iodosulfuron-methyl-sodium, nicosulfuron, prosulfuron, rimsulfuron, trifloxysulfuron-sodium or tritosulfuron and a polyoxyalkylene alkyl ether phosphate
Inventor: YOSHII HIROSHI
IPC: A01N25/30
Filed: 2007-03-13
Abstract: Disclosed is a herbicidal composition which comprises (1) a herbicidal sulfonylurea compound or its salt selected from flazasulfuron, foramsulfuron, halosulfuronmethyl, iodosulfuron-methyl-sodium, nicosulfuron, prosulfuron, rimsulfuron, trifloxysulfuron-sodium or tritosulfuron; and (2) a polyoxyalkylene alkyl ether phosphate or its salt; wherein the mix ratio of (1) the herbicidal sulfonylurea compound or its salt to (2) the polyoxyalkylene alkyl ether phosphate or its salt is from 13:1 to 1:10,000 by weight ratio. Further disclosed is a method for controlling undesired plants or inhibiting their growth, which comprises applying to the undesired plants or to a place where they grow a composition as defined above.
Patent NZ-580342-A (NZ)
Title: Hot temperature aerated dairy product comprising a high melting point fat and a mixture of gums such as gelatin or carrageenan
Inventor: BARNARD DAVID JOHN
IPC: A23L29/281
Filed: 2009-10-12
Abstract: Disclosed is an aerated dairy product composition comprising a dairy food base, a fat source at least partially comprising a high-melting point fat having a melting point between about 100°F to about 110ºF (such as palm oil, palm kernel oil, coconut oil or hydrogenated soybean oil), and a hydrocolloid-based stabilizer system in an amount effective to provide an organoleptically-pleasing, high-moisture shelf stable, hot-temperature aerated dairy food product; wherein the dairy food product is aerated at a sufficient temperature for microstability and subsequently hot-filled into packages while maintaining its aerated structure; wherein the hydrocolloid-based system comprises at least two gums where one of the gums is gelatin or at least three gums where one of the gums is gelatin or carrageenan; and wherein the dairy food product has a shelf life of at least three months at ambient temperature.
Patent NZ-585699-A (NZ)
Title: Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
Inventor: BOSCO MARCO
IPC: A61K8/73
Filed: 2008-11-20
Abstract: Disclosed are acid polysaccharides selected from hyaluronic acid, chondroitin sulphate, dermatan sulphate, heparan sulphate and cheratan sulphate, characterised by the concomitant presence of alcohol groups esterified with butyric and formic acids. Process for the preparation of acid polysaccharides is also disclosed, which comprises: (a) dissolving the acid polysaccharide, salified with sodium or other alkali metals, in formamide by heating (wherein the solubilisation temperature of polysaccharide in formamide is between 60 Deg C and 120 Deg C); (b) adding butyric anhydride to the resulting solution, at room temperature, in the presence of an organic base, (wherein the base is an aromatic or aliphatic organic base such as dimethylaminopyridine or triethylamine); (c) diluting the homogenous, viscous reaction mixture with an aqueous solution of sodium chloride (NaCl) and neutralising it to pH 6-7.5;(d) purifying the dilute reaction mixture by dialysis or tangential filtration; and(e) freezing the purified polysaccharide solution and recovering the product by freeze-drying or spray-drying.
Patent NZ-585887-A (NZ)
Title: Disposable nasal plug for absorbing excess nasal fluid
Inventor: SCOTT PHILLIPA KAY
IPC: A61M31/00
Filed: 2010-10-15
Abstract: A device for absorbing excess nasal fluid is disclosed. The device, made from a unitary piece of absorbent material, comprises a body, a stop, and a pair of absorbent pads. The body comprises a pair of prongs where each prong is for positioning in a users nasal passage and the stop prevents further insertion of the prongs into the nasal passages. One of the pair of absorbent pads is positioned on each prong and configured to exert a gentle pressure upon the Kiesselbach's area of the nasal mucosa and absorb excess nasal fluid from the nasal passage.
Patent NZ-588740-A (NZ)
Title: 3d imaging system
Inventor: DANIEL RONALD
IPC: G06T7/00
Filed: 2009-03-27
Abstract: An apparatus and a method for computing a three dimensional model of an object (101) are disclosed. The apparatus comprises a portable, hand-held instrument comprising multiple directional energy sources (106-109) arranged to directionally illuminate the object; an imaging sensing assembly (104) having at least two spatially separated viewpoints (111, 112) at fixed positions relative to each other, at least one localisation template (102, 103) having predetermined geometrical features and a processor (110). The imaging sensing assembly is arranged to record a series of images of the object at each viewpoint when the object is illuminated by each of the sources. The localisation template is arranged in use to be visible to at least one of the viewpoints simultaneously with the object. The processor is arranged to analyse the images recorded at the viewpoints, so as to determine the location and pose of each viewpoint relative to the template for each image in the series of images; generate photometric data for the object using the calculated location and pose of the viewpoints and the direction of illumination from each energy source; generate geometric data comprising a skeleton three dimensional model of the object by performing stereoscopic reconstruction using optical triangulation so as to provide the gross-scale shape of the object; and combine the geometric data and photometric data by using the photometric data to provide high-frequency geometric detail onto the gross-scale shape so as to construct the three dimensional model.
Patent NZ-590073-A (NZ)
Title: Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
Inventor: VENDEVILLE SANDRINE MARIE HELENE
IPC: A61K31/55
Filed: 2009-07-08
Abstract: Disclosed is a indolo[2,1-a][2]benzazepine of Formula I including stereochemically isomeric forms, and N-oxides, salts, hydrates, and solvates thereof, wherein the variables are defined in the specification for treating hepatitis C virus.
Patent NZ-591196-A (NZ)
Title: A VSD material in a curable liquid form having conductive rods and dilectric fillers at the nano scale
Inventor: LUSSEY DAVID
IPC: H01C10/10
Filed: 2009-08-27
Abstract: 591196 Disclosed is a method of producing a composite material capable of transition to a resilient electrically responsive composite material for application in a transducer, in which the resilient electrically responsive material is configured to experience a change in an electrical property in response to exposure to a form of applied energy. The method comprises the steps of receiving a flowable polymer liquid capable of transition to a resilient material and introducing electrically conductive acicular particles to the flowable polymer liquid to facilitate the conduction of electricity by quantum tunnelling. Dielectric particles are added to the flowable polymer liquid and both the acicular particles and the dielectric particles are mixed within the flowable polymer liquid. The acicular particles have a large dimension and a small dimension, the small dimension and the size of the dielectric particles being between 10 nanometres and 300 nanometres. A plurality of the dielectric particles are dispersed between adjacent acicular particles during the step of mixing, and the dielectric particles consisting of dielectric material only and being in a form that is separate from the electrically conductive acicular particles.
Patent NZ-592035-A (NZ)
Title: A lolium multiflorum line inducing genome loss
Inventor: KINDIGER BRYAN K
IPC: A01H5/12
Filed: 2009-09-25
Abstract: Disclosed is a Lolium multiflorum diploid plant or parts thereof which segregates for levels of pollen sterility and where upon using the Lolium as the maternal parent in an interspecific hybridization with a Festuca species, being utilized as the paternal parent, confers to the resultant sterile F1 interspecific hybrids the ability to produce some seed via parthenogenesis that also possess a viable embryo, wherein said seeds which possess a viable embryo, may develop into F2 generation plants at least some of which are dihaploid homozygous Festuca species comprising a karyotype exhibiting a balanced genome of Festuca chromosomes equivalent to the chromosome number of said Festuca paternal parent and no Lolium chromosomes.
Patent NZ-594178-A (NZ)
Title: An ex vivo method of predicting toxicity to tyrosine kinase inhibitors
Inventor: BACUS SARAH S
IPC: A61K45/00
Filed: 2007-02-27
Abstract: 594178 Provided is an ex vivo method for predicting toxicity in response to treatment with a tyrosine kinase inhibitor drug, said method comprising, identifying whether a cell oxidizes fatty acids in response to treatment with a drug, wherein the drug is predicted to be toxic to the cell where the cell is identified to not oxidize fatty acids in response to treatment with the drug or wherein the drug is predicted to not be toxic to the cell where the cell is identified to oxidize fatty acids in response to treatment with the drug.
Patent NZ-597766-A (NZ)
Title: A picture hanging device comprising 2 similar components with one component on the wall and the other on the picture
Inventor: PRIESTLEY BRIAN PETER
IPC: A47F5/08
Filed: 2012-05-21
Abstract: A wall hanging device formed by two opposing duplicate components 1, 2 conjoined together with semicircular tangs 3 inserting into the wider aperture V-shaped straight walled cavities. The semicircular tangs 3 are able to rotate on the side walls of the cavities with frictional resistance at the contact points between the tangs 3 and the cavities side walls being produced by the thirty six degree angle of the cavity walls and the downwards pressure of the weight of an attached object. The frictional resistance assists the rotated components to remain in the desired position.
Patent NZ-606047-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23L33/00
Filed: 2009-04-28
Abstract: The disclosure relates to a method comprising: processing a biomass material comprising a plant-derived pharmaceutical to provide a processed material, wherein processing comprises irradiation, sonication, pyrolysis, oxidation and combinations thereof. The method disclosed can be used to effect: purification/isolation, production, increased pharmaceutical activity and altered pharmaceutical activity of the plant derived pharmaceuticals. Compounds that may be processed in such a manner include: salicin (derived from willow bark), allontoin (derived from comfrey), benzoin, camphor (derived from camphor basil), ephedrine (derived from Ephedra), atropine (derived from Duboisia myoporoides), L-dopa (derived from mucuna deeringiana), physosigmine (derived from Physostigma venenosum) bromelain, chymopapain, cocaine, deserpidine, emetine, hyoscyamine, kawaina, monocrotaline, ouabain, papain, pilocarpine, quinidine, quinine, rescirmami, reserpine, scopolamine, tubocurarine, vinblastine, yohimbine, caprylic-acid, cineole, citric acid, codeine, cresol, guaiacol, lecithin, menthol, phenol pseudephedrine, sorbitol, and tartaric acid.
Patent NZ-614975-A (NZ)
Title: Ectoparasiticidal methods and formulations
Inventor: MEYER JEFFERY ALAN
IPC: A01N43/22
Filed: 2010-06-16
Abstract: Disclosed are pharmaceutical spot-on formulations of Spinetoram. The compositions may comprise spinetoram or a pharmaceutically acceptable salt thereof is present in said formulation in an amount of 1 to 45% by weight of the formulation, may be formulated for administration no more than every two weeks in a single or pulse dose, may be formulated for administration no more than monthly, may be formulated for administration to a dog or cat, may further comprise; benzyl alcohol and/or butylated hydroxytoluene.
Patent NZ-627530-A (NZ)
Title: Combination adjuvant formulation
Inventor: ELLIOTT MELISSA
IPC: A61P31/12
Filed: 2014-08-13
Abstract: Disclosed is an adjuvant composition comprising (a) a host defence peptide selected from ILPWKWPWWPWRR, VQLRIRVAVIRA; VQRWLIVWRIRK; VRLIVAVRIWRR; and Ile-Dhb-Ala-Ile-Dha-Leu-Ala-Abu-Pro-Gly-Ala-Lys-Abu-Gly-Ala-Leu-Met-Gly-Ala-Asn-Met-Lys-Abu-Ala-Abu-Ala-Asn-Ala-Ser-Ile-Asn-Val-Dha-Lys; (b) an immunostimulatory sequence selected from (i) a CpG oligonucleotide selected from TCCATGACGTTCCTGACGTT; TCGTCGTTGTCGTTTTGTCGTT; TCGTCGTTTTGTCGTTTTGTCGTT; and TCGTCGTTTTCGGCGCGCGCCG; and (ii) poly (I:C); (c) a bovine viral diarrhoea virus (BVDV) antigen; and (d) a polyanionic polymer, wherein the polyanionic polymer is poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP), poly(di-4-oxyphenylproprionate)phosphazene (PCEP), or a PCPP polymer comprising 90% PCPP copolymer with 10% hydroxyl groups (90:10 PCPP), wherein said adjuvant composition is capable of enhancing an immune response to the BVDV antigen as compared to the immune response elicited by an equivalent amount of the BVDV antigen when delivered without the adjuvant composition.
Patent NZ-629462-A (NZ)
Title: Filter vial with limited piston stroke
Inventor: KISHAN G HINGORANI
IPC: B01L3/14
Filed: 2014-08-28
Abstract: Disclosed is a filter vial apparatus that has a piston limit stop to prevent the piston filter from travelling into any contaminants located in the base of the vial. The filter vial apparatus having a longitudinal axis, comprising: a tubular vial having a closed bottom, an open top and a sidewall extending therebetween and defining a periphery around the open top, the sidewall having an interior height H between the bottom and the open top; a tubular piston with opposing distal and proximal ends with at least the distal end being open, the piston having walls defining a hollow interior, the piston having at least one seal configured to sealingly engage the sidewall of the vial abut an inner circumference of the sidewall when the piston is inserted into the vial, the piston having a position stop extending outward from the piston a distance sufficient to abut the periphery around the open top of the vial; a piston filter connected to the distal end of the filter and blocking the distal end of the piston so any fluid must pass through the filter to enter the hollow interior from the distal end of the piston, the piston and piston filter forming a filter assembly, the position stop being located a distance L from the distal end of the piston assembly, the distance L being less than the height H to limit the distance which the piston assembly may be inserted into the filter vial during use.
Patent NZ-629795-A (NZ)
Title: 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
Inventor: KIMMERLIN THIERRY
IPC: C07D519/00
Filed: 2013-02-01
Abstract: Disclosed herein are compounds of Formula (II) and pharmaceutically acceptable salts thereof, wherein the substituents are as described in the description. Specific examples of the compounds of formula II include 1-{ (R)-4-[4-(1H-Benzoimidazol-2-yl)-2-trifluoromethyl-thiazol-5-yl]-2-methyl-piperazin-1-yl} -2-[4-(1-methylpiperidin-4-yl)-pyrazol-1-yl]-ethanone and 2-imidazo[4,5-b]pyridin-3-yl-1-{ (R)-4-[4-(3H-imidazo[4,5-b]pyridin-2-yl)-2-trifluoromethyl-thiazol-5-yl]-2-methylpiperazin-1-yl} -ethanone. The compounds are modulators of the CXCR3 receptor and may be useful in the treatment of autoimmune diseases.
Patent NZ-630390-A (NZ)
Title: Medical analysis method
Inventor: BRISEBRAT JEAN-MICHEL
IPC: G01N35/10
Filed: 2013-03-08
Abstract: A medical analysis method (100) that uses an automated medical analyser provided with a poly-articulated robot (70) comprising articulations defining at least six axes of rotation and designed to move and/or orient an end member with six degrees of freedom. The end member bears a gripping member designed to grip a container (16). The medical analysis method comprises at least the following successive steps consisting in: supplying a container (16) containing a sample; transferring the container to a treatment station (34); treating the sample; transferring the container to an image capture station (48); and displaying the treatment results. The sample to be treated, may be of human or animal origin. The transferring to a treatment station of the automated medical analyser (100) is performed using the poly-articulated robot (70). The treatment results may be displayed on a user interface. The treatment container can be a gel card suitable for centrifuging.
Patent NZ-631027-A (NZ)
Title: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
Inventor: BANVILLE JACQUES
IPC: C07D519/00
Filed: 2013-04-24
Abstract: The present disclosure provides thiazole compounds of Formula I wherein W, Y, R0, R2, R4, R5, R6, R7, X1, X2, X3 and X4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
Patent NZ-700922-A (NZ)
Title: Multilayer pipeline in a polymer material, device for manufacture of the multilayer pipeline and a method for manufacturing the multilayer pipeline
Inventor: OPHAUG ARVID
IPC: B29C48/09
Filed: 2013-03-14
Abstract: The invention relates to a multilayer pipeline for transporting petroleum products, in particular for oil and gas, and for transporting CO2 gas. Plastic composite pipes and pipes that include a metal are presently known and are restricted by length, rigidity and pressuration at least. The present invention seeks to ameliorate such disadvantages. More particularly, the invention relates to an endless multilayer pipeline (1) which includes at least: - an inner fluid-tight ply (11) which is formed of a first thermoplastic polymer material; an inner fibre-reinforced thermoplastic polymer ply (14) which includes a wrapped fibre-reinforcement and which surrounds the inner fluid-tight ply; a first intermediate ply (13) which is formed of a second thermoplastic polymer material; an outer fibre-reinforced thermoplastic polymer ply (12) which includes a wrapped fibre reinforcement, wherein at least one of the inner fibre-reinforced thermoplastic polymer ply (14) and the outer fibre-reinforced thermoplastic polymer ply (12) includes at least one fibre-containing layer (14a-b, 14c-d; 12a-b, 12c-d) and one reinforcement-free layer (14c, 14f; 12c, 12f), wherein the wrapped fibre-reinforcement includes at least one fibre tape (4), and the first intermediate ply (13) is provided with at least one first channel oriented axially. A machine assembly (30) for producing the multilayer pipeline (1) and a method of producing the multilayer pipeline (1) are described as well.